Yahoo Finance

Acasti Pharma Presents CaPre Clinical Data at National Lipid Association Scientific Sessions

LAVAL, QUEBEC--(Marketwired - May 18, 2017) - Acasti Pharma Inc. (ACST.V)(TSX VENTURE:ACST) today announced the presentation of the CaPre® (omega-3 phospholipid) bridging study results at the ...
Business Insider

Acasti Pharma Releases Preliminary New Animal Data, and Gains Insights Into CaPre’s Novel Mechanism of Action in Diabetes

Data from a new preclinical mouse study suggests a unique mechanism of CaPre compared to metformin and icosapent ethyl (VASCEPA®) in a diet-induced obesity animal model Preliminary, statistically ...
Yahoo Finance

Acasti Pharma Reports Positive CaPre Omega-3 Bridging Study Data

LAVAL, QUEBEC--(Marketwired - Sep 14, 2016) - Acasti Pharma (ACST)(TSX VENTURE:APO) today announced that its bridging study for novel drug candidate CaPre® (omega-3 phospholipid) has successfully met ...
Nasdaq

ACST's CaPre Misses Goal Again, AIMT Snapped Up By Nestle, CRMD To Face FDA In Feb, VIR & COVID-19

(RTTNews) - Today's Daily Dose brings you news about Acasti Pharma's phase III trial of CaPre, Merger Monday, CorMedix's regulatory catalyst, Vanda Pharma's anticipated milestones, and the progress in ...